GlassScriptPhysician profile
Avik Mukherjee
NPI 1629607130
$13,354.45
in general payments reported to CMS, 2019-2025
21 companies · $3,818 in 2025
The $3,818 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $3,567 · 2023: $3,277 · 2024: $2,413 · 2025: $3,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,846 · Food and Beverage: $4,483 · Long Term Medical Supply Or Device Loan: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,845.66 |
| Food and Beverage | $4,483.03 |
| Long Term Medical Supply Or Device Loan | $179.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $4,744.93 | 2023-2025 | Portfolio, Apex 3d, Bun-Yo-Matic |
| Medwest Associates | $2,419.15 | 2022 | |
| Acumed LLC | $1,350.82 | 2023 | Osteomed, Acumed |
| Stryker Corporation | $1,240.46 | 2022-2024 | Hoffmann, Prostep, Citrefix |
| Kerecis Limited | $841.25 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Arthrex, INC. | $696.40 | 2025 | |
| Seapearl East, INC | $580.25 | 2023-2025 | |
| Horizon Therapeutics Plc | $250.08 | 2021-2023 | Krystexxa |
| Orthofix Medical, INC. | $225.29 | 2021-2025 | Physio-Stim |
| Integra Lifesciences Corporation | $179.03 | 2024 | Integra Dermal Regeneration Template |
| Organogenesis INC. | $170.18 | 2022-2025 | Puraply Wound Matrix |
| Medela LLC | $143.26 | 2022 | |
| Extremity Medical | $125.40 | 2024 | |
| Biotissue Holdings INC. | $112.53 | 2022 | |
| Averitas Pharma INC. | $72.01 | 2024-2025 | Qutenza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $58.86 | 2025 | Prospera |
| Depuy Synthes Sales INC. | $45.64 | 2022-2025 | Lcp |
| Pacira Pharmaceuticals Incorporated | $33.82 | 2025 | Exparel |
| Nevro Corp. | $28.08 | 2024 | Senza |
| Fidia Pharma USA INC. | $20.45 | 2025 | Triluron, Hymovis |
| Advanced Oxygen Therapy INC. | $16.56 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avik Mukherjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.